vs
肯纳金属（KMT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是肯纳金属的1.2倍（$622.0M vs $529.5M），Royalty Pharma plc净利率更高（34.4% vs 6.4%，领先28.0%），肯纳金属同比增速更快（9.8% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.3%）
肯纳金属是高性能切削工具及工程部件制造商，产品广泛应用于航空航天、国防、交通运输、油气钻探等领域，业务覆盖全球市场，为各行业客户提供适配高要求作业场景的专业解决方案。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
KMT vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$529.5M
营收增速更快
KMT
高出5.1%
4.8%
净利率更高
RPRX
高出28.0%
6.4%
两年增速更快
RPRX
近两年复合增速
1.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $529.5M | $622.0M |
| 净利润 | $33.9M | $214.2M |
| 毛利率 | 32.8% | — |
| 营业利润率 | 9.9% | 62.4% |
| 净利率 | 6.4% | 34.4% |
| 营收同比 | 9.8% | 4.8% |
| 净利润同比 | 89.0% | 2.9% |
| 每股收益（稀释后） | $0.44 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMTRPRX
| Q4 25 | $529.5M | $622.0M | ||
| Q3 25 | $498.0M | $609.3M | ||
| Q2 25 | $516.4M | $578.7M | ||
| Q1 25 | $486.4M | $568.2M | ||
| Q4 24 | $482.1M | $593.6M | ||
| Q3 24 | $481.9M | $564.7M | ||
| Q2 24 | $543.3M | $537.3M | ||
| Q1 24 | $515.8M | $568.0M |
净利润KMTRPRX
| Q4 25 | $33.9M | $214.2M | ||
| Q3 25 | $23.3M | $288.2M | ||
| Q2 25 | $21.6M | $30.2M | ||
| Q1 25 | $31.5M | $238.3M | ||
| Q4 24 | $17.9M | $208.2M | ||
| Q3 24 | $22.1M | $544.0M | ||
| Q2 24 | $37.2M | $102.0M | ||
| Q1 24 | $19.0M | $4.8M |
毛利率KMTRPRX
| Q4 25 | 32.8% | — | ||
| Q3 25 | 31.0% | — | ||
| Q2 25 | 28.2% | — | ||
| Q1 25 | 32.1% | — | ||
| Q4 24 | 30.1% | — | ||
| Q3 24 | 31.3% | — | ||
| Q2 24 | 31.5% | — | ||
| Q1 24 | 29.7% | — |
营业利润率KMTRPRX
| Q4 25 | 9.9% | 62.4% | ||
| Q3 25 | 7.5% | 70.1% | ||
| Q2 25 | 6.1% | 36.3% | ||
| Q1 25 | 9.1% | 94.0% | ||
| Q4 24 | 6.6% | 60.9% | ||
| Q3 24 | 7.5% | — | ||
| Q2 24 | 11.3% | 50.2% | ||
| Q1 24 | 6.8% | -13.0% |
净利率KMTRPRX
| Q4 25 | 6.4% | 34.4% | ||
| Q3 25 | 4.7% | 47.3% | ||
| Q2 25 | 4.2% | 5.2% | ||
| Q1 25 | 6.5% | 41.9% | ||
| Q4 24 | 3.7% | 35.1% | ||
| Q3 24 | 4.6% | 96.3% | ||
| Q2 24 | 6.8% | 19.0% | ||
| Q1 24 | 3.7% | 0.8% |
每股收益（稀释后）KMTRPRX
| Q4 25 | $0.44 | $0.49 | ||
| Q3 25 | $0.30 | $0.67 | ||
| Q2 25 | $0.28 | $0.07 | ||
| Q1 25 | $0.41 | $0.55 | ||
| Q4 24 | $0.23 | $0.46 | ||
| Q3 24 | $0.28 | $1.21 | ||
| Q2 24 | $0.47 | $0.23 | ||
| Q1 24 | $0.24 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.3M | $618.7M |
| 总债务越低越好 | $597.2M | $9.0B |
| 股东权益账面价值 | $1.3B | $9.7B |
| 总资产 | $2.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资KMTRPRX
| Q4 25 | $129.3M | $618.7M | ||
| Q3 25 | $103.5M | $938.9M | ||
| Q2 25 | $140.5M | $631.9M | ||
| Q1 25 | $97.5M | $1.1B | ||
| Q4 24 | $121.2M | $929.0M | ||
| Q3 24 | $119.6M | $950.1M | ||
| Q2 24 | $128.0M | $1.8B | ||
| Q1 24 | $92.1M | $843.0M |
总债务KMTRPRX
| Q4 25 | $597.2M | $9.0B | ||
| Q3 25 | $597.0M | $8.9B | ||
| Q2 25 | $596.8M | $8.0B | ||
| Q1 25 | $596.6M | $7.6B | ||
| Q4 24 | $596.4M | $7.6B | ||
| Q3 24 | $596.2M | $7.6B | ||
| Q2 24 | $596.0M | $7.6B | ||
| Q1 24 | $595.8M | $6.1B |
股东权益KMTRPRX
| Q4 25 | $1.3B | $9.7B | ||
| Q3 25 | $1.3B | $9.6B | ||
| Q2 25 | $1.3B | $9.5B | ||
| Q1 25 | $1.2B | $9.8B | ||
| Q4 24 | $1.2B | $10.3B | ||
| Q3 24 | $1.3B | $10.3B | ||
| Q2 24 | $1.2B | $9.8B | ||
| Q1 24 | $1.3B | $9.9B |
总资产KMTRPRX
| Q4 25 | $2.6B | $19.6B | ||
| Q3 25 | $2.5B | $19.3B | ||
| Q2 25 | $2.5B | $18.3B | ||
| Q1 25 | $2.5B | $17.6B | ||
| Q4 24 | $2.4B | $18.2B | ||
| Q3 24 | $2.5B | $18.0B | ||
| Q2 24 | $2.5B | $17.7B | ||
| Q1 24 | $2.5B | $16.1B |
负债/权益比KMTRPRX
| Q4 25 | 0.45× | 0.92× | ||
| Q3 25 | 0.46× | 0.93× | ||
| Q2 25 | 0.46× | 0.84× | ||
| Q1 25 | 0.48× | 0.78× | ||
| Q4 24 | 0.49× | 0.74× | ||
| Q3 24 | 0.47× | 0.74× | ||
| Q2 24 | 0.48× | 0.78× | ||
| Q1 24 | 0.47× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $42.4M | — |
| 自由现金流率自由现金流/营收 | 8.0% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | 1.63× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $99.3M | — |
8季度趋势，按日历期对齐
经营现金流KMTRPRX
| Q4 25 | $55.1M | $827.1M | ||
| Q3 25 | $17.5M | $702.6M | ||
| Q2 25 | $78.6M | $364.0M | ||
| Q1 25 | $28.8M | $596.1M | ||
| Q4 24 | $55.2M | $742.5M | ||
| Q3 24 | $45.7M | $703.6M | ||
| Q2 24 | $113.6M | $658.2M | ||
| Q1 24 | $75.2M | $664.6M |
自由现金流KMTRPRX
| Q4 25 | $42.4M | — | ||
| Q3 25 | $-5.5M | — | ||
| Q2 25 | $57.1M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $35.9M | — | ||
| Q3 24 | $21.0M | — | ||
| Q2 24 | $90.3M | — | ||
| Q1 24 | $48.4M | — |
自由现金流率KMTRPRX
| Q4 25 | 8.0% | — | ||
| Q3 25 | -1.1% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 16.6% | — | ||
| Q1 24 | 9.4% | — |
资本支出强度KMTRPRX
| Q4 25 | 2.4% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 5.2% | — |
现金转化率KMTRPRX
| Q4 25 | 1.63× | 3.86× | ||
| Q3 25 | 0.75× | 2.44× | ||
| Q2 25 | 3.64× | 12.06× | ||
| Q1 25 | 0.92× | 2.50× | ||
| Q4 24 | 3.08× | 3.57× | ||
| Q3 24 | 2.07× | 1.29× | ||
| Q2 24 | 3.06× | 6.45× | ||
| Q1 24 | 3.96× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KMT
| Metal Cutting | $331.1M | 63% |
| Infrastructure | $198.5M | 37% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
